Octreotide Lp Teva (Octreotide Acetate)

Octreotide acetate, the active ingredient in Octreotide Lp Teva, is a somatostatin analogue presented as a sterile solution for subcutaneous injection use. It regulates hormone secretion and is employed in the management of hormone‑secreting tumours and related complications.

GNH USA supplies Octreotide Lp Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Octreotide Lp Teva is a synthetic somatostatin analogue that modulates neuro‑endocrine pathways and is indicated for several endocrine‑related conditions. - Acromegaly: reduces growth hormone and IGF‑1 levels, helping control disease activity. - Carcinoid syndrome: lessens flushing and diarrhoea associated with serotonin release. - VIPoma‑related diarrhea: provides symptomatic relief by inhibiting vasoactive intestinal peptide. - Prevention of postoperative SRS SRS post‑   --- -  ...

Octreotide Lp Teva offers ​   g  ....

Oct‑